BR100 Decreased By (-0.25%)
BR30 Decreased By (-0.64%)
KSE100 Decreased By (-0.41%)
KSE30 Decreased By (-0.67%)
BECO 5.83 Decreased By ▼ -0.20 (-3.32%)
BML 57.90 Increased By ▲ 5.15 (9.76%)
BOP 33.79 Decreased By ▼ -0.46 (-1.34%)
CNERGY 8.15 Decreased By ▼ -0.01 (-0.12%)
DCL 11.79 Decreased By ▼ -0.55 (-4.46%)
FCCL 53.49 Decreased By ▼ -0.40 (-0.74%)
FCSC 5.40 Increased By ▲ 0.18 (3.45%)
FFL 17.84 Decreased By ▼ -0.19 (-1.05%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.11 Increased By ▲ 0.11 (1%)
KEL 8.02 Decreased By ▼ -0.09 (-1.11%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.40 Decreased By ▼ -0.65 (-0.74%)
NBP 184.24 Decreased By ▼ -2.24 (-1.2%)
PACE 11.62 Increased By ▲ 0.90 (8.4%)
PAEL 40.25 Increased By ▲ 0.31 (0.78%)
PIAHCLA 26.12 Decreased By ▼ -0.05 (-0.19%)
PIBTL 17.14 Decreased By ▼ -0.18 (-1.04%)
PPL 228.73 Decreased By ▼ -4.05 (-1.74%)
PRL 34.49 Decreased By ▼ -0.46 (-1.32%)
PTC 67.54 Decreased By ▼ -0.02 (-0.03%)
SEARL 90.93 No Change ▼ 0.00 (0%)
SSGC 26.83 Decreased By ▼ -0.34 (-1.25%)
TELE 8.53 Decreased By ▼ -0.04 (-0.47%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.33 Increased By ▲ 0.57 (6.51%)
TREET 24.51 Decreased By ▼ -0.03 (-0.12%)
TRG 71.61 Decreased By ▼ -0.14 (-0.2%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)

The Special Assistant on Health Dr Zafar Mirza on Saturday announced that long-awaited National Medicine Policy will be announced by end of next month. Dr Zafar Mirza, while addressing a seminar in Rawalpindi, predicted that the pharmaceutical sector will witness revolutionary changes in the near future. The special assistant detailed that an outline on the constitution of the country's medicine policy had been prepared in a high-meeting which was attended by the representatives of pharmaceutical companies and other stakeholders from all four provinces.

Earlier in May, Dr Zafar Mirza had said that the government has decided to present a new national medicines policy to regulate the pharmaceutical industry and controlling the prices of the drug. The minister had said that the new policy is being made in consultation with all stakeholders to ensure availability of life-saving drugs and keeping prices of all drugs in reach of a layman, a state news agency reported on May 16.

He said that the new medicines policy will also cover the aspect of rules and regulations to streamline the production of medicines and maintaining its quality as per international standard. Dr Mirza said that under this policy, the government will also get inputs from the stakeholders for announcing more incentives for the pharma industry in order to convince those producing standard medicines in the market. He said that the new policy will also manage the issues related to the sale of medicines without prescription of medical practitioners and open sale of unauthorized medicines to customers.

He revealed plans that the government decided to make Drug Regulatory Authority of Pakistan (DRAP) a model regulatory authority with the introduction of new reforms in order to facilitate the people and addressing the issues of quality and pricing of drugs.

Copyright News Network International, 2019

Comments

Comments are closed for this article.